PreprintAll rights reservedbioRxiv
Therapeutic Potential of Melatonin, Erythropoietin, and TRPV4 Antagonism in a Preclinical Model of Genetic Hydrocephalus
- 1Indiana University Indianapolis
Related
- Editorial: Potential therapeutic targets in alcohol use disorder: insights from recent preclinical studies
- Therapeutic potential of oncolytic viruses in hematopoietic malignancies: from preclinical insights to clinical realities
- Pharmacological and Therapeutic Potential of Garlic ( Allium sativum ): Integrating Phytochemistry, Molecular Mechanisms, and Clinical and Preclinical Evidence
- Therapeutic Potential of Propolis in Ulcerative Colitis: A Review of Preclinical Evidence.
- The Therapeutic Potential of Berry-Derived and Berry-Based Interventions in Inflammatory Bowel Disease: A Comprehensive Systematic Review of Preclinical and Clinical Evidence
BibTeX
@misc{bidgoli2026therapeutic,
title = {{Therapeutic Potential of Melatonin, Erythropoietin, and TRPV4 Antagonism in a Preclinical Model of Genetic Hydrocephalus}},
author = {F. Omidi Bidgoli and D. Audu and G. Mahendran and Y. Zhang and L. Jantzie and R. Shenandoah and B. Blazer-Yost},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.05.764645},
url = {https://www.biorxiv.org/content/10.64898/2026.11.05.764645v1},
}
RIS
TY - UNPB
TI - Therapeutic Potential of Melatonin, Erythropoietin, and TRPV4 Antagonism in a Preclinical Model of Genetic Hydrocephalus
AU - F. Omidi Bidgoli
AU - D. Audu
AU - G. Mahendran
AU - Y. Zhang
AU - L. Jantzie
AU - R. Shenandoah
AU - B. Blazer-Yost
PY - 2026
DA - 2026/11/05
PB - bioRxiv
DO - 10.64898/2026.11.05.764645
UR - https://www.biorxiv.org/content/10.64898/2026.11.05.764645v1
ER -